Machine learning identifies a candidate NEC expression signature with experimental checks
Source check: Source checked. Not independent scientific confirmation.
Finding: RF+XGBoost screening identified SLC26A3, CCL20 and CXCL5 as a candidate expression signature for neonatal necrotizing enterocolitis, with retrospective expression validation and new mouse and cell-model expression checks. The study used 46 training and 24 test samples; the reported 0.979 AUC is training performance, with 0.917 and 0.957 in two small test cohorts. Geneformer and virtual-knockout analyses generated regulatory hypotheses; causality, protein-level diagnostic performance and clinical benefit remain unestablished.
Technology: Random forest; XGBoost; Geneformer
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- RF+XGBoost screening links expression data to three NEC candidate genes; 46 training and24 independent retrospective test samples.
- Test and result
- Mouse and cell-model expression checks corroborated candidate-gene directions; diagnostic evaluation used retrospective human datasets.
- Limitation / still unknown
- Clinical diagnostic utility, causal regulatory interactions and treatment efficacy remain unestablished.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13240151/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 21 Nov 2026. Review scope: Primary full paper Methods, Results and limitations plus Europe PMC bibliographic metadata;reviewed 2026-11-21..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.